DICE Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
64.43
|
|
Average Rating
|
4.86
|
|
# Strong Buys
|
6
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.81
|
0.00
|
0.81
|
100.00%
|
|
2022-12-31
|
-0.48
|
0.00
|
0.48
|
100.00%
|
|
2022-09-30
|
-0.60
|
-0.55
|
0.05
|
8.33%
|
|
2022-06-30
|
-0.56
|
-0.58
|
-0.02
|
-3.57%
|
|
2022-03-31
|
-0.54
|
-0.50
|
0.04
|
7.41%
|
|
2021-12-31
|
-0.58
|
-0.44
|
0.14
|
24.14%
|
|
2021-09-30
|
-0.50
|
-2.30
|
-1.80
|
-360.00%
|
|
2021-06-30
|
0.00
|
-0.65
|
-0.65
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.63
|
|
2021-12-31
|
-4.25
|
|
2020-12-31
|
-1.45
|
|
2019-12-31
|
-0.59
|